Hyperuricemia is Associated with Immunoglobulin G
glycan biomarkers
glycan diagnostics
glycosylation
hyperuricemia
personalized medicine
public health
Journal
Omics : a journal of integrative biology
ISSN: 1557-8100
Titre abrégé: OMICS
Pays: United States
ID NLM: 101131135
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
pubmed:
6
3
2019
medline:
9
6
2020
entrez:
6
3
2019
Statut:
ppublish
Résumé
The increasing prevalence of hyperuricemia has been recognized as an emerging public health concern in both developed and developing countries. Hyperuricemia is a metabolic condition characterized by an elevated serum uric acid, and associated with renal damage, diabetes, autoimmune disorders, and cardiovascular diseases. Although human genetic variation has been recognized as a factor, posttranslational cellular processes and glycan biomarkers have not been studied extensively for susceptibility to hyperuricemia. We evaluated whether immunoglobulin (Ig)G
Identifiants
pubmed: 30835642
doi: 10.1089/omi.2019.0004
doi:
Substances chimiques
Biomarkers
0
Immunoglobulin G
0
Polysaccharides
0
glycosylated IgG
0
Uric Acid
268B43MJ25
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM